CRISPRMED27 - CRISPR Medicine

The 4th CRISPR MEDiCiNE Conference (CRISPRMED27) | Hybrid | Copenhagen, Denmark | April 19–22, 2027

CRISPRMED27 brings together the global CRISPR and gene editing ecosystem for four days of scientific exchange, translational innovation, regulatory dialogue, patient perspectives, and industry collaboration in Copenhagen, Denmark, April 19-22, 2027.

As a fully hybrid event, the 4th edition of the CRISPR Medicine Conference is expected to welcome more than 1,000 onsite and online participants, including pioneering researchers, biotech and pharma leaders, clinicians, investors, patient advocates, regulators, technology providers, and patients and families helping shape the future of genomic medicine.

Attendees will gain access to a highly curated scientific programme featuring cutting-edge research, clinical and translational advances, regulatory perspectives, patient voices, hands-on workshops, satellite meetings, and emerging commercial opportunities across the CRISPR and gene editing landscape.

CRISPRMED27 uniquely connects science, medicine, industry, regulation, infrastructures and patient communities to accelerate the future of genomic medicine for rare diseases and complex cancers.

More details on speakers, committees, programme details, workshops, satellite meetings, and participation opportunities will be announced in the coming weeks.

Sign up to the CRISPRMED27 Newsletter

---------------

The CMN Global Clinical Trials Database 2.0 in now live...

Interested to learn more about the Sponsorship or Exhibitor Packages?

Sponsorship packages and limited number of exhibitor spaces (#20) will be available at CRISPRMED27. Contact us today to learn more.

Sorry - something went wrong, your inquiry has not been sent!!

Thanks for your interest for The 4th CRISPR Medicine Conference 2027. We will soon share more details.

Name

Company

I accept the terms and conditions below

GDPR Consent & Privacy Notice for Form Submission

By submitting this form, you agree that CRISPR Medicine Media ApS (CVR-DK-39130327) can collect and process the personal data you provide to respond to your request and communicate with you about our products and services.

What data we collect:
• Company name
• Your name
• Your email address
• Any additional information you include in the form

Why we collect it & legal basis:
We process your personal data to:
• Respond to your enquiry and provide the information you requested;
• Send follow-up communications relevant to the product or service you asked about.
The legal basis for this processing is your explicit consent and our legitimate interest in responding to your enquiry.

How long we keep your data:
Your personal data will be retained only as long as necessary to fulfil the purposes above, or as required by applicable law.

Who has access to your data:
Your data is used by authorised staff of CRISPR Medicine News ApS. We do not share your personal data with third parties unless required by law.

Your rights:
Under the GDPR, you have the right to:
• Request access to your personal data;
• Request correction or deletion of your data;
• Withdraw your consent at any time without affecting the lawfulness of processing based on consent before its withdrawal;
• Object to the processing of your personal data or request restriction of processing;
• Lodge a complaint with a supervisory authority if you believe your rights under the GDPR have been violated.

If you have any questions about our use of your personal data or wish to exercise your rights, please contact us at: sales@crisprmedicinenews.com

Interested to learn more about the Sponsorship or Exhibitor Packages?

CRISPRMED27 Supporters (early confirmation)